13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0000909661
Total reported value
$21.7B
$21.7B
5 檔
5.5%
The Q2 2024 SEC filing reveals that Farallon Capital Management, L.l.c. held a total portfolio value of $21.7B, covering 5 public equity positions.
Farallon Capital Management, L.l.c. executed strategic sector rebalancing during Q2 2024, establishing 8 new positions while fully exiting 7 holdings and trimming 18 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | HES | Hess CORP | Stock-Other | 83.78% | — | +5.44% | |
| 2 | AKX | Ansys Inc | Stock-Other | 6.87% | — | — | |
| 3 | USX1 | United States Steel CORP | Stock-Other | 5.41% | — | -46.40% | |
| 4 | APY1EUR | Championx CORP | Stock-Other | 2.18% | — | — | |
| 5 | DFSEUR | Discover Financial Services | Stock-Other | 1.75% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | IWM | Ishares Russell 2000 ETF | +4.1% | NEW | New buy |
| 2 | DIS | Walt Disney Co/the | +1.7% | NEW | New buy |
| 3 | AON | Aon plc | +1.6% | — | Add |
| 4 | CRM | Salesforce Inc | +0.9% | — | Add |
| 5 | MRNA | Moderna Inc | +0.7% | NEW | New buy |
| 6 | RVMD | Revolution Medicines Inc | +0.7% | — | Add |
| 7 | NTRA | Natera Inc | +0.7% | — | Add |
| 8 | LNTH | Lantheus Holdings Inc | +0.4% | — | Add |
| 9 | AZNN | Astrazeneca Plc-spons Adr | +0.4% | — | Add |
| 10 | AGIO | Agios Pharmaceuticals Inc | +0.4% | — | Add |
| 11 | SRPT | Sarepta Therapeutics Inc | +0.4% | — | Trim |
| 12 | INTU | Intuit Inc | +0.4% | — | Add |
| 13 | AMGN | Amgen Inc | +0.3% | NEW | New buy |
| 14 | NOW | Servicenow Inc | +0.3% | — | Add |
| 15 | EDU | New Oriental Educatio-sp Adr | +0.3% | — | Add |
| 16 | CERE1EUR | Cerevel Therapeutics Holding | +0.2% | NEW | New buy |
| 17 | GERN | Geron CORP | +0.2% | — | Add |
| 18 | MSFT | Microsoft CORP | +0.2% | — | Trim |
| 19 | PTGX | Protagonist Therapeutics Inc | +0.2% | — | Add |
| 20 | NYT | New York Times Co-a | +0.2% | — | Trim |
| 21 | BEAM | Beam Therapeutics Inc | +0.2% | — | Add |
| 22 | INSM | Insmed Inc | +0.2% | NEW | New buy |
| 23 | FLUT | Flutter Entertainment plc | +0.2% | NEW | New buy |
| 24 | BHVN | Biohaven Ltd. | +0.2% | — | Add |
| 25 | V | Visa Inc-class A Shares | +0.2% | — | Add |
| 26 | CRSP | CRISPR Therapeutics AG | +0.1% | NEW | New buy |
| 27 | THC | Tenet Healthcare CORP | +0.1% | — | Add |
| 28 | COR | Cencora Inc | -0.1% | — | Trim |
| 29 | HIMS | Hims & Hers Health Inc | -0.1% | — | Trim |
| 30 | HWM | Howmet Aerospace Inc | -0.1% | — | Trim |
| 31 | IONS | Ionis Pharmaceuticals Inc | -0.1% | — | Trim |
| 32 | EVH | Evolent Health Inc - A | -0.2% | EXIT | Sold out |
| 33 | MA | Mastercard Inc - A | -0.2% | — | Trim |
| 34 | TMO | Thermo Fisher Scientific Inc | -0.2% | — | Trim |
| 35 | TRU | Transunion | -0.2% | — | Trim |
| 36 | XBI | Ss Spdr S&p Biotech ETF | -0.2% | EXIT | Sold out |
| 37 | CBRE | Cbre Group Inc - A | -0.3% | — | Trim |
| 38 | CNC | Centene CORP | -0.3% | — | Trim |
| 39 | NDAQ | Nasdaq Inc | -0.3% | — | Trim |
| 40 | SHW | Sherwin-williams Co/the | -0.3% | — | Trim |
| 41 | WAB | Wabtec CORP | -0.3% | — | Trim |
| 42 | MASI* | Masimo CORP | -0.3% | — | Trim |
| 43 | IQV | Iqvia Holdings Inc | -0.3% | — | Add |
| 44 | GBTC | Grayscale Bitcoin Trust ETF | -0.4% | EXIT | Sold out |
| 45 | VSTS | Vestis CORP | -0.4% | EXIT | Sold out |
| 46 | INSP | Inspire Medical Systems Inc | -0.6% | EXIT | Sold out |
| 47 | GOOG | Alphabet Inc-cl C | -0.7% | — | Trim |
| 48 | CSGP | Costar Group Inc | -1.1% | EXIT | Sold out |
| 49 | PXDEUR | Pioneer Natural Resources Co | -4.2% | EXIT | Sold out |
| 50 | SPY | Ss Spdr S&p 500 ETF Trust-us | -4.5% | — | Trim |
According to official SEC Form 13F filings, Farallon Capital Management, L.l.c. reported a total U.S. public equity portfolio value of $21.7B across 5 disclosed positions in Q2 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including HES, AKX, USX1) accounted for 5.5% of total reported equity market value during Q2 2024.
Top New Position Initiated
IWM
市值: $862.3M
Top Position Liquidated / Trimmed
PXDEUR
前期市值: $924.0M
During Q2 2024, Farallon Capital Management, L.l.c.'s top holdings by market value included HES (83.8%)、AKX (6.9%)、USX1 (5.4%). The largest single position, HES, represented 83.8% of total portfolio value.
In Q2 2024, Farallon Capital Management, L.l.c. made 50 total portfolio adjustments, initiating 8 new buys, adding to 17 positions, trimming 18 holdings, and fully liquidating 7 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.